Saturday night fever: Finding and controlling the source of sepsis in critical illness

Lancet Infectious Diseases

Volumn 2, Issue 3, 2002, Pages 137-144

  Rizoli, Sandro B ^a   Mashall, John C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANTIBIOTIC THERAPY; BLOOD CULTURE; CASE REPORT; CLINICAL EXAMINATION; CRITICAL ILLNESS; FEVER; HUMAN; INFECTION; INTENSIVE CARE UNIT; MALE; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SEPSIS;

EID: 0036236629     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(02)00220-7     Document Type: Review

References (72)

1. Cooking in the intensive care unit: Evaluation of the febrile patient
2. A prospective study of fever in the intensive care unit
3. Contemporary issues with bacterial infection in the intensive care unit
4. Practice guidelines for evaluating new fever in critically ill adult patients
5. Fever patterns. Their lack of clinical significance
6. Fever in the intensive care unit
7. The clinical significance of fever patterns
8. Drug fever: A critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature
9. Drug fever
10. Complications on a general surgery service: Incidence and reporting
11. Candidemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy
12. Hypothermia in the sepsis syndrome and clinical outcome
13. Effects of ibuprofen on the physiology and survival of hypothermic sepsis
14. Antipyresis and fever
15. Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis
16. The effects of physical treatment on induced fever in humans
17. Fever in the ICU
18. Combating hyperthermia in acute stroke: A significant clinical concern
19. The adaptive value of fever
20. Postoperative fever
21. Evidence for the non-infectious etiology of early postoperative fever
22. Lack of association between atelectasis and fever
23. A model of pulmonary atelectasis in rats: Activation of alveolar macrophage and cytokine release
24. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients
25. Nonhemolytic, noninfectious transfusion reactions
26. Perioperative haemotherapy: II. Risks and complications of blood transfusion
27. Fever without source
28. Imaging evaluation of patients with acute abdominal pain and fever
29. Acute acalculous cholecystitis
30. Acute acalculous cholecystitis: Incidence, risk factors, diagnosis, and outcome
31. Percutaneous cholecystostomy in acute cholecystitis in high-risk patients: An analysis of 69 patients
32. Percutaneous cholecystectomy for patients with acute cholecystitis and an increased surgical risk
33. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study
34. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients
35. Ventilator associated pneumonia: Perspectives on the burden of illness
36. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia
37. Comparison of direct examination of three types of bronchoscopy specimens used to diagnose nosocomial pneumonia
38. Accuracy of portable chest radiography in the critical care setting. Diagnosis of pneumonia based on quantitative cultures obtained from protected brush catheter
39. Ventilator associated pneumonia: Perspectives on the burden of illness
40. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial
41. Diagnosis and treatment of ventilator-associated pneumonia-impact on survival. A decision analysis
42. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia
43. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit
44. The value of routine microbial investigation in ventilator-associated pneumonia
45. The influence of mini-BAL cultures on patient outcomes: Implications for the antibiotic management of ventilator-associated pneumonia
46. Antibiotic resistance in the intensive care unit
47. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay
48. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription
49. Guidelines for the management of intravascular catheter-related infections
50. Complications of femoral and subclavian venous catheterization in critically ill patients: A randomized controlled trial
51. A comparison of two antimicrobial-impregnated central venous catheters
52. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial
53. Complications of femoral and subclavian venous catheterization in critically ill patients: A randomised controlled trial
54. Central venous catheter replacement strategies: A systematic review of the literature
55. Association of rectal and urethral colonization with urinary tract infection in patients with indwelling catheters
56. Catheter-associated urinary tract infections
57. Value of antral puncture in the intensive care patient with fever of unknown origin
58. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill
59. A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia
60. A-mode diagnostic ultrasound of maxillary sinuses: Possibilities and limitations
61. Paranasal sinus imaging
62. Update on diagnosis of Clostridium difficile-associated diarrhoea
63. Incidence and impact of Clostridium difficile infection in the UK, 1993-1996
64. The epidemiology and typing of Clostridium difficile
65. Clostridium difficile-associated diarrhoea: Epidemiology, risk factors, and infection control
66. The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii
67. The lack of therapeutic effect of Saccharomyees boulardii in the prevention of antibiotic-related diarrhoea in elderly patients
68. Soft tissue infections and the diabetic foot
69. Epidemiology of invasive mycosis in ICU patients: A prospective multicenter study in 435 non-neutropenic patients
70. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia
71. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria
72. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting